Safety and efficacy data from sateen trial in multiple sclerosis
Por:
Acevedo, BR, Lopez, R, Oreja, C, Ramio, L, Ramo, C, Alonso, A, Merino, JAG, Rodriguez, JEM, Gutierrez, S, Xaus, J and Montalban, X
Publicada:
1 oct 2021
Resumen:
Filiaciones:
Acevedo, BR:
Univ Autonoma Barcelona, Vall dHebron Hosp Univ, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain
Lopez, R:
Hosp Univ Virgen Macarena, Seville, Spain
Oreja, C:
Univ Complutense Madrid, Hosp Clin San Carlos, Madrid, Spain
Ramio, L:
Hosp Josep Trueta, Girona, Spain
:
Hosp Germans Tries & Pujol, Badalona, Spain
Alonso, A:
Hosp Reg Univ Malaga, Malaga, Spain
Merino, JAG:
Hosp Puerta Hierro, Madrid, Spain
Rodriguez, JEM:
Hosp Mar Med, Res Inst, IMIM, Unitat dEsclerosi Multiple,Servei Neurol, Barcelona, Spain
Gutierrez, S:
ORYZON GENOM SA, Cornella De Llobregat, Spain
Xaus, J:
ORYZON GENOM SA, Cornella De Llobregat, Spain
Montalban, X:
Univ Autonoma Barcelona, Vall dHebron Hosp Univ, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain
|